Biotechnology News

September 3, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced it has received a notice of allowance...

September 3, 2014

WASHINGTON--(BUSINESS WIRE)--BIO today congratulates member company POET-DSM on opening Project Liberty, a 20-million gallon per year cellulosic ethanol biorefinery in Emmetsburg, Iowa.

September 3, 2014

SAN DIEGO--(BUSINESS WIRE)--Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM), announced today that Christopher J Reinhard, Chief Executive Officer, will present at the 16th Annual Rodman & Renshaw Annual Global Investment...

September 3, 2014

SAN ANTONIO--(BUSINESS WIRE)--KCI, LifeCell and Systagenix Combine to Form One Company and Rebrand as Acelity; Acelity is Industry Leading Medical Technology Company with $2 Billion in Revenue

September 3, 2014

BOSTON--(BUSINESS WIRE)--Kerafast celebrates a milestone - 100th Partner Institution, the University of Texas at Austin. Through its unique online platform, Kerafast offers life science reagents from academic researchers.

September 3, 2014

WAKEFIELD, Mass.--(BUSINESS WIRE)--Use of catheters containing the Agion® antimicrobial is among the recommended strategies to control central line-associated bloodstream infections according to SHEA.

September 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScience to Present at the Rodman & Renshaw/H.C. Wainwright Annual Global Investment Conference

September 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Industry leaders, Eric K. Rowinsky, M.D. and Amy W. Schulman, join BIND’s Board of Directors

September 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra to Present Data at ICAAC on VIS513, its Humanized Monoclonal Antibody That Targets a Conserved Site on the Dengue Virus E Protein

September 3, 2014

JUPITER, Fla.--(BUSINESS WIRE)--BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced it has been...

September 3, 2014

TENAFLY, N.J.--(BUSINESS WIRE)--Exostar, whose cloud-based solutions enable secure, cost-effective information sharing and collaboration among pharmaceutical, healthcare, and other industries, has been approved as a Full Service Credential...

September 3, 2014

LOS ANGELES--(BUSINESS WIRE)--Data from Puma Biotechnology's Phase II trial of neratinib for NSCLC with HER2 mutations will be presented in a late-breaking oral presentation on Sept. 29 at the ESMO 2014 Congress.

September 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--German biotech company sphingotec GmbH, developer of a breast cancer biomarker test, is establishing its U.S. headquarters in Cambridge, Massachusetts, and has appointed Karla M. Gonye as president.

September 3, 2014

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Protalex, Inc. (OTCQB:PRTX), a clinical-stage biopharmaceutical company, today announced that an abstract highlighting results from Cohorts 1-4 of its U.S.-based multicenter Phase 1(b) randomized, multiple-...

September 3, 2014

PLYMOUTH, Mich.--(BUSINESS WIRE)--ProNAi Therapeutics, Inc., a developer of novel nucleic acid therapeutics, announces the appointment Nick Glover, Ph.D. as President and Chief Executive Officer. The company’s previous CEO, Mina Sooch, will be...

September 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIOGEN IDEC DATA AT JOINT ACTRIMS-ECTRIMS MEETING HIGHLIGHT ROBUST MULTIPLE SCLEROSIS PORTFOLIO AND COMMITMENT TO ADVANCING PATIENT CARE

September 3, 2014

FRAZER, Pa.--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced the launch of SYNCareTM, a comprehensive program designed to support patients taking SYNRIBO® (omacetaxine mepesuccinate) for injection, for...

September 3, 2014

SAN MATEO, Calif.--(BUSINESS WIRE)--EndoGastric Solutions Announces Publication of Comparative Results for TIF Procedure vs. Traditional Anti-Reflux Surgery Techniques

September 3, 2014

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI reports updated enrollment numbers for its Phase III head and neck cancer clinical trial for August 2014.

September 3, 2014

SAN DIEGO--(BUSINESS WIRE)--CIDARA THERAPEUTICS TO PRESENT DATA FROM ANTIFUNGAL DRUG DEVELOPMENT PROGRAM AT ICAAC

September 3, 2014

CHANDLER, Ariz.--(BUSINESS WIRE)--For innovation on behalf of patients, investments in product line development, and its rapidly escalating growth curve, Insys Therapeutics, Inc. named the 2014 Arizona Bioscience Company of the Year.

September 3, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--PaxVax has announced the appointment of Mark Meltz as Executive Vice President and Chief Legal Officer.

September 3, 2014

PHILADELPHIA--(BUSINESS WIRE)--Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the company has secured favorable decisions from key Managed Care...

September 3, 2014

WESTPORT, Conn.--(BUSINESS WIRE)--Intensity Therapeutics appoints Ian B. Walters M.D., MBA as Vice President and Chief Medical Officer. Dr. Walters will oversee the company's clinical activities and drug safety programs.

September 3, 2014

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced it has signed a new agreement with Premier, Inc. to offer the complete illumigene® molecular menu of tests to its members. Premier serves more...

September 3, 2014

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of...

September 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Voyager Therapeutics, a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS), today announced that Steven Paul, M.D., has been...

September 3, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), today announced that it has appointed Frank McGillin as Senior Vice President and General Manager, Consumer. Mr. McGillin will be responsible for development of a consumer...

September 3, 2014

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P. Hobbs, President and Chief Executive Officer and Robert F. Apple, Chief Financial Officer and President of the Parenteral Products Group, will...

September 3, 2014

EMERYVILLE, Calif. & SHANGHAI--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, and China Pioneer...

September 3, 2014

KFAR SABA, Israel--(BUSINESS WIRE)--CartiHeal announces the issuance of four patents for its proprietary cell-free, off-the-shelf cartilage regeneration technology for patients with injuries to the articular surface of joints

September 3, 2014

JERUSALEM--(BUSINESS WIRE)--BioLineRx Doses First Patient for BL-8040’s Second Indication as Novel Stem Cell Mobilization Treatment. Results from Phase 1 trial expected by end of 2014 or early 2015

September 3, 2014

CAMBRIDGE, Mass. & NORTH CHICAGO, Ill.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and AbbVie Inc. (NYSE: ABBV) today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI...

September 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has entered into a master clinical supply agreement with Roche under which Roche will supply GazyvaTM (obinutuzumab) to Infinity for use in...

September 3, 2014

MARBURG, Germany--(BUSINESS WIRE)--Surgeons Complete Cancer Surgery with Medrobotics’ Flex® System in Front of a Live Audience at Head and Neck Surgical Course at University Hospital of Marburg

September 3, 2014

CAMBRIDGE, England--(BUSINESS WIRE)--Eagle Genomics, a bioinformatics software and services company, has launched Eaglecore™, a software platform to improve bioinformatics research

September 3, 2014

GENEVA--(BUSINESS WIRE)--GeNeuro Successful Phase 2a Clinical Study Reinforces Novel Approach to Treat Multiple Sclerosis

September 3, 2014

TOULOUSE, France & ANN ARBOR, Michigan--(BUSINESS WIRE)--Cerenis has received 2 Orphan Drug Designations from the EMA for CER-001 in patients with rare genetic defects in HDL synthesis/maturation pathways.

September 3, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro announces that it has purchased the assets of IROC Innocross AG, of Zug, Switzerland.

September 3, 2014

CHANDLER, Ariz.--(BUSINESS WIRE)--What do over 400 life science leaders, Arizona students, innovative companies and accredited investors have in common? They are all participating in Arizona Bioscience Week events and you can too.

September 3, 2014

DALLAS--(BUSINESS WIRE)--Vivione Biosciences Inc. launched its Petro Chemical Bio-Diagnostics bacterial identification and enumeration solution this past week at the Unconventional Resources & Technologies Conference (URTeC).

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) announces that management will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 10, 2014 at 2.30 PM ( EDT) at the Grand Hyatt New York Hotel,...

September 2, 2014

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that Richard Baron, Senior Vice President and Chief Financial Officer, will present at the 2014 Morgan Stanley Global...

September 2, 2014

CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced the publication of preclinical data demonstrating that lead...

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today the appointment of Thomas Graney as chief financial officer (CFO) and senior vice president of finance and corporate strategy, and the appointment of...

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that Jason Rhodes, President...

September 2, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the Company will participate in the...

September 2, 2014

DUBLIN--(BUSINESS WIRE)--Mallinckrodt plc. (NYSE: MNK), a leading global specialty pharmaceutical company, will hold an investor briefing on Tuesday, October 14, 2014, in New York City. Mark Trudeau, President and Chief Executive Officer of...

September 2, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that, subject to market and other conditions, it intends to offer $200 million aggregate principal amount of its convertible senior notes due 2021 (the “notes...